Asia-Pacific Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers validation and testing), by Application (Risk Assessment, Development of molecular diagnostics, Disease diagnosis, Drug discovery and Development and Drug formulation), by Type (Protein Biomarkers, Genetic biomarkers and Other biomarkers), by Profiling Technologies (Omics technologies, Imaging technologies, Immunoassays, Cytogenetics, Bioinformatics and IVD multivariate index assays) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Asia-Pacific Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers validation and testing), by Application (Risk Assessment, Development of molecular diagnostics, Disease diagnosis, Drug discovery and Development and Drug formulation), by Type (Protein Biomarkers, Genetic biomarkers and Other biomarkers), by Profiling Technologies (Omics technologies, Imaging technologies, Immunoassays, Cytogenetics, Bioinformatics and IVD multivariate index assays) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 2242 | Pages: 139 | May 2017 | Region: Asia Pacific


The Asia-Pacific Cancer Biomarkers Market was worth USD 2.07 billion in 2016 and estimated to be growing at a CAGR of 12.6%, to reach USD 3.75 billion by 2021. The Asia-Pacific market is expected to grow at a fast pace with consistent economic development.

Cancer biomarkers are substances that are an indicative of the presence of cancer in the body. With the emerging importance to quantify and validate various disease conditions, many organizations, companies, and universities have stepped forward to contribute to the field of biomarkers discovery and quantification for better prognosis of disease conditions.

The Biomarkers in pharmaceutical industry, biomarkers in oncology & other diseases has attained utmost recognition due to global spread of cancer and other diseases. Factors such as technological Developments in omics technologies, augmented demand for personalized medicines in cancer therapies and increased use of biomarkers in drug discovery development and clinical trials are anticipated to boost the growth of the cancer biomarkers market during the forecast period. Lack of awareness about the procedure among people is restraining the market growth.

The Asia-Pacific cancer biomarkers market is segmented on the basis of disease into Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers. Based on services market is divided into Sample Preparation, Assay development and Biomarkers validation and testing. On the basis of application, market is bifurcated into Risk Assessment, Development of molecular diagnostics, Disease diagnosis, Drug discovery and Development and Drug formulation. By Type, the cancer biomarkers market is segregated into Protein Biomarkers, Genetic biomarkers and other biomarkers. Based on profiling technologies, segmentation is among omics technologies, Imaging technologies, Immunoassays, Cytogenetics, Bioinformatics and IVD multivariate index assays. Omics technologies segment is further sub segmented into Genomics, Proteomics, Metabolomics, Transcriptomics and Pharmacogenomics.

Based on geography, the market is analysed under various countries namely, China, India, Japan, South Korea and Australia. China is dominating the cancer biomarkers market and estimated to grow at highest CAGR in the forecast period.

Some of the major players in this market are Abbott Laboratories, Agendia Bv, Biocurex Inc, Biomerieux S.A., Biomoda Inc, Astellas Pharma Us Inc, Correlogic Systems Inc, Beckman Coulter Inc, Becton, Dickinson And Company, Clarient Inc, Diadexus Inc, Ambrilia Biopharma, Affymetrix Inc and Aureon Laboratories Inc.

1.Introduction                                                                  

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Disease                                                        

                                5.1.1 Introduction                                           

                                5.1.2 Prostate Cancer                                    

                                5.1.3 Breast Cancer                                        

                                5.1.4 Lung Cancer                                            

                                5.1.5 Colorectal Cancer                                 

                                5.1.6 Cervical Cancer                                      

                                5.1.7 Other Cancers                                       

                                5.1.8  Y-o-Y Growth Analysis, By Disease                                               

                                5.1.9  Market Attractiveness Analysis, By Disease                                             

                                5.1.10  Market Share Analysis, By Disease                                            

                5.2 Services                                                       

                                5.2.1 Introduction                                           

                                5.2.2 Sample Preparation                                            

                                5.2.3 Assay development                                            

                                5.2.4 Biomarkers validation and testing                                 

                                5.2.5  Y-o-Y Growth Analysis, By Services                                              

                                5.2.6  Market Attractiveness Analysis, By Services                                            

                                5.2.7  Market Share Analysis, By Services                                             

                5.3 Application                                                 

                                5.3.1 Introduction                                           

                                5.3.2 Risk Assessment                                   

                                5.3.3 Development of molecular diagnostics                                       

                                5.3.4 Disease diagnosis                                 

                                5.3.5 Drug discovery                                      

                                5.3.6 Development and Drug formulation                                            

                                5.3.7  Y-o-Y Growth Analysis, By Application                                        

                                5.3.8  Market Attractiveness Analysis, By Application                                      

                                5.3.9  Market Share Analysis, By Application                                       

                5.4 Type                                                              

                                5.4.1 Introduction                                           

                                5.4.2 Protein Biomarkers                                             

                                5.4.3 Genetic biomarkers                                            

                                5.4.4 genetic biomarkers                                             

                                5.4.7  Y-o-Y Growth Analysis, By Type                                    

                                5.4.8  Market Attractiveness Analysis, By Type                                  

                                5.4.9  Market Share Analysis, By Type                                    

                5.5 Profiling Technologies                                                            

                                5.5.1 Omics technologies                                             

                                                5.5.1.1 Genomics                            

                                                5.5.1.2 Proteomics                          

                                                5.5.1.3 Metabolomics                    

                                                5.5.1.4 Transcriptomics                 

                                                5.5.1.5 Pharmacogenomics                         

                                5.5.2 Imaging technologies                                         

                                5.5.3 Immunoassays                                      

                                5.5.4 Cytogenetics                                          

                                5.5.5 Bioinformatics                                       

                                5.5.6 IVD multivariate index assays                                         

                                5.5.7  Y-o-Y Growth Analysis, By Profiling Technologies                                  

                                5.5.8  Market Attractiveness Analysis, By Profiling Technologies                                                

                                5.5.9  Market Share Analysis, By Profiling Technologies                                  

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Disease                           

                                                6.1.3.3 By Services                          

                                                6.1.3.4 By Application                    

                                                6.1.3.5 By Type                 

                                                6.1.3.6 Profiling Technologies                    

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Disease                           

                                                6.1.4.3 By Services                          

                                                6.1.4.4 By Application                    

                                                6.1.4.5 By Type                 

                                                6.1.4.6 Profiling Technologies                    

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Disease                           

                                                6.1.5.3 By Services                          

                                                6.1.5.4 By Application                    

                                                6.1.5.5 By Type                 

                                                6.1.5.6 Profiling Technologies                    

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

                6.6 Australia                                                      

7.Strategic Analysis                                                                        

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                                                                         

                8.1 Abbott Laboratories                                                               

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Agendia Bv                                                 

                8.3 Biocurex Inc                                                               

                8.4 Biomerieux S.A.                                                        

                8.5 Biomoda Inc                                                               

                8.6 Astellas Pharma Us Inc                                                          

                8.7 Correlogic Systems Inc                                                           

                8.8 Beckman Coulter Inc                                                              

                8.9 Becton                                                          

                8.10 Dickinson And Company                                                     

                8.11 Clarient Inc                                                               

                8.12 Diadexus Inc                                                            

                8.13 Ambrilia Biopharma                                                              

                8.14 Affymetrix Inc                                                         

                8.15 Aureon Laboratories Inc.                                                    

9.Competitive Landscape                                        &

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  2. Asia-Pacific Prostate Cancer Market By Region, From 2016-2021 ( USD Billion )
  3. Asia-Pacific Breast Cancer Market By Region, From 2016-2021 ( USD Billion )
  4. Asia-Pacific Lung Cancer Market By Region, From 2016-2021 ( USD Billion )
  5. Asia-Pacific Colorectal Cancer Market By Region, From 2016-2021 ( USD Billion )
  6. Asia-Pacific Cervical Cancer  Market By Region, From 2016-2021 ( USD Billion )
  7. Asia-Pacific Other Cancers Market By Region, From 2016-2021 ( USD Billion )
  8. Asia-Pacific Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  9. Asia-Pacific Sample Preparation Market By Region, From 2016-2021 ( USD Billion )
  10. Asia-Pacific Assay development  Market By Region, From 2016-2021 ( USD Billion )
  11. Asia-Pacific Biomarkers validation and testing Market By Region, From 2016-2021 ( USD Billion )
  12. Asia-Pacific Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  13. Asia-Pacific Risk Assessment Market By Region, From 2016-2021 ( USD Billion )
  14. Asia-Pacific Development of molecular diagnostics Market By Region, From 2016-2021 ( USD Billion )
  15. Asia-Pacific Disease diagnosis Market By Region, From 2016-2021 ( USD Billion )
  16. Asia-Pacific Drug discovery  Market By Region, From 2016-2021 ( USD Billion )
  17. Asia-Pacific Development and Drug formulation Market By Region, From 2016-2021 ( USD Billion )
  18. Asia-Pacific Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  19. Asia-Pacific Protein Biomarkers Market By Region, From 2016-2021 ( USD Billion )
  20. Asia-Pacific Genetic biomarkers  Market By Region, From 2016-2021 ( USD Billion )
  21. Asia-Pacific Other biomarkers Market By Region, From 2016-2021 ( USD Billion )
  22. Asia-Pacific Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  23. Asia-Pacific Omics technologies  Market By Region, From 2016-2021 ( USD Billion )
  24. Asia-Pacific Imaging technologies Market By Region, From 2016-2021 ( USD Billion )
  25. Asia-Pacific Immunoassays Market By Region, From 2016-2021 ( USD Billion )
  26. Asia-Pacific Cytogenetics Market By Region, From 2016-2021 ( USD Billion )
  27. Asia-Pacific Bioinformatics Market By Region, From 2016-2021 ( USD Billion )
  28. Asia-Pacific IVD multivariate index assays Market By Region, From 2016-2021 ( USD Billion )
  29. Japan Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  30. Japan Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  31. Japan Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  32. Japan Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  33. Japan Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  34. China Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  35. China Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  36. China Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  37. China Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  38. China Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  39. India Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  40. India Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  41. India Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  42. India Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  43. India Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  44. Australia Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  45. Australia Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  46. Australia Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  47. Australia Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  48. Australia Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  49. South Korea Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  50. South Korea Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  51. South Korea Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  52. South Korea Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  53. South Korea Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  54. Asia-Pacific Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  55. Asia-Pacific Genomics Market By Region, From 2016-2021 ( USD Billion )
  56. Asia-Pacific Proteomics Market By Region, From 2016-2021 ( USD Billion )
  57. Asia-Pacific Metabolomics Market By Region, From 2016-2021 ( USD Billion )
  58. Asia-Pacific Transcriptomics Market By Region, From 2016-2021 ( USD Billion )
  59. Asia-Pacific Pharmacogenomics Market By Region, From 2016-2021 ( USD Billion )
  60. Japan Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  61. China Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  62. India Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  63. Australia Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
Middle-East and Africa Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and ...
Latin America Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarker...
Asia-Pacific Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers...
Europe Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers valid...
North America Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarker...
Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers validation a...
Middle East and Africa Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Car...
Latin America Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascul...
Asia-Pacific Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascula...
Europe Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascular) –...
North America Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascul...
Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascular) - Global M...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.